These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4022949)

  • 1. Hydatidiform mole in Nottingham: a 12-year retrospective epidemiological and morphological study.
    Womack C; Elston CW
    Placenta; 1985; 6(2):93-105. PubMed ID: 4022949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
    Joneborg U; Folkvaljon Y; Papadogiannakis N; Lambe M; Marions L
    Acta Oncol; 2018 Aug; 57(8):1094-1099. PubMed ID: 29451409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases in Turkey.
    Ozalp SS; Oge T
    J Reprod Med; 2013; 58(1-2):67-71. PubMed ID: 23447922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy.
    Wairachpanich V; Limpongsanurak S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2015; 16(18):8321-5. PubMed ID: 26745079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydatidiform mole as seen in a university teaching hospital: a 10-year review.
    Audu BM; Takai IU; Chama CM; Bukar M; Kyari O
    J Obstet Gynaecol; 2009 May; 29(4):322-5. PubMed ID: 19835501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.
    Lund H; Vyberg M; Eriksen HH; Grove A; Jensen AØ; Sunde L
    Sci Rep; 2020 Oct; 10(1):17041. PubMed ID: 33046739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
    Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hydatidiform mole in a Tokyo hospital: a 5-year (1989 to 1993) prospective, morphological, and flow cytometric study.
    Fukunaga M; Ushigome S; Endo Y
    Hum Pathol; 1995 Jul; 26(7):758-64. PubMed ID: 7628848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
    Hancock BW; Nazir K; Everard JE
    J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
    Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping.
    Colgan TJ; Chang MC; Nanji S; Kolomietz E
    Int J Gynecol Cancer; 2016 Sep; 26(7):1345-50. PubMed ID: 27258730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and aetiology of hydatidiform mole: an epidemiological review.
    Bracken MB
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1123-35. PubMed ID: 3322372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible association between hydatidiform mole and the COVID-19 pandemic: A retrospective cohort study.
    Aiob A; Naskovica K; Sharon A; Bornstein J
    Gynecol Oncol; 2021 May; 161(2):454-457. PubMed ID: 33712273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after hydatidiform mole, initial and recurrent.
    Yapar EG; Ayhan A; Ergeneli MH
    J Reprod Med; 1994 Apr; 39(4):297-9. PubMed ID: 8040847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study.
    Joneborg U; Eloranta S; Johansson AL; Marions L; Weibull CE; Lambe M
    Am J Obstet Gynecol; 2014 Dec; 211(6):681.e1-7. PubMed ID: 24949537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydatidiform mole in gombe: a five year Histopathological review.
    Mayun AA
    Niger J Clin Pract; 2008 Jun; 11(2):134-8. PubMed ID: 18817053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydatidiform mole in England and Wales 1973-83.
    Bagshawe KD; Dent J; Webb J
    Lancet; 1986 Sep; 2(8508):673-7. PubMed ID: 2876145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.